The venture capital situation for medical device companies is the worst it has been since the darkest times of the Great Recession, according to a recent report by EP Vantage. And the IPO environment is pretty bad, too.

With $670 million raised, the second quarter of 2016 was the worst money raise for medtech companies since the first quarter of 2009, according to EP Vantage.

The average deal size during the second quarter was $25 million, the largest it has been since early 2000. And EP Vantage says that is not good news, either: "It in fact means that a handful of companies are getting most of the cash available and leaving the rest  ghting over the scraps."

With the second quarter often the best quarter of the year, it could be slim pickings for medtech VC for the rest of 2016.

The major problem remains lack of an exit for the venture capital investors. The big companies are demanding that companies they acquire not only have regulatory approvals, but they also sometimes want reimbursements and revenues in place, according to EP Vantage.  Meanwhile, the IPO window appears to have shut for now, too, with only three listings on U.S. and European exchanges during the first half of 2016.

10 Device Technologies That Got VC Love in Early 2016

10 Medtech Startups on Fire in Q2 2016

Continue >>

[Image by I, JerryFriedman, CC BY-SA 3.0]